Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Circulating Cell-free microRNA Profile in Systemic Sclerosis Is Distinct from Both Healthy Controls and Systemic Lupus Erythematosus

15 Nov 2014

Abstract excerpt

OBJECTIVE: To evaluate the expression profile of cell-free circulating microRNA (miRNA) in systemic sclerosis (SSc), healthy controls (HC), and systemic lupus erythematosus (SLE). METHODS: Total RNA was purified from plasma and 45 different, mature miRNA were measured using quantitative PCR assays after reverse transcription. Samples (n = 189) were from patients with SSc (n = 120), SLE (n = 29), and from HC (n =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective Tissue Growth Factor Research
Share to MicroRNA in disease regulation
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25399392
DOI: 10.3899/jrheum.140502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Circulating Cell-free microRNA Profile in Systemic Sclerosis Is Distinct from Both Healthy Controls and Systemic Lupus ErythematosusPMID 25399392Read ↗

Circulating MicroRNA Expression Profiles Associated With Systemic Lupus ErythematosusSemantic proximity Read ↗

MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.Semantic proximity Read ↗

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosisSemantic proximity Read ↗

Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAsSemantic proximity Read ↗

Identification of lncRNA–miRNA–mRNA networks in circulating exosomes as potential biomarkers for systemic sclerosisSemantic proximity Read ↗

MicroRNA-29: a potential therapeutic target for systemic sclerosisSemantic proximity Read ↗

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in sclerodermaSemantic proximity Read ↗

The Role of Non‐Coding RNA in Systemic Sclerosis: From Mechanism to TranslationSemantic proximity Read ↗

Hsa_circ_0000479 as a Novel Diagnostic Biomarker of Systemic Lupus ErythematosusSemantic proximity Read ↗

MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndromeSemantic proximity Read ↗

Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.